Wolverine Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,161
Closed -$162K 2837
2022
Q3
$162K Buy
+8,161
New +$108K ﹤0.01% 1297

Wolverine Asset Management's FMTX Position: Q4 2022 in Review

Wolverine Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 8,161 shares — an estimated $162K sold.

Wolverine Asset Management first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $162K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Wolverine Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 8,161 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $162K.
  • Wolverine Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Wolverine Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $162K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.